3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
6
Phase 1
2
Status
Completed
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
2
Conditions
Carcinoma, Hepatocellular
37
Liver Neoplasms
20
Neoplasms
17
Leukemia, Myeloid, Acute
13
Neoplasm Metastasis
11
Carcinoma, Renal Cell
9
Carcinoma, Non-Small-Cell Lung
9
Pancreatic Neoplasms
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Melanoma
7
Breast Neoplasms
6
Brain Neoplasms
6
Unspecified Adult Solid Tumor, Protocol Specific
5
Prostatic Neoplasms
5
Multiple Myeloma
5
Lung Neoplasms
5
Kidney Neoplasms
5
Recurrence
4
Glioblastoma
4
Colorectal Neoplasms
4
Sarcoma
3
Rectal Neoplasms
3
Myelodysplastic Syndromes
3
Leukemia, Promyelocytic, Acute
3
Leukemia, Myelomonocytic, Acute
3
Leukemia, Monocytic, Acute
3
Leukemia, Megakaryoblastic, Acute
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Leukemia, Erythroblastic, Acute
3
Leukemia, Eosinophilic, Acute
3
Interventions
pembrolizumab
26
Gemcitabine
20
Cisplatin
12
Nivolumab
11
Carboplatin
8
Paclitaxel
7
Docetaxel
7
atezolizumab
6
durvalumab
5
Radiotherapy
5
fludarabine
4
enfortumab vedotin
4
Ipilimumab
4
Cyclophosphamide
4
Vorinostat
3
Magnetic Resonance Spectroscopy
3
Fluorouracil
3
Filgrastim
3
Doxorubicin
3
zimberelimab
2
vocimagene amiretrorepvec
2
tremelimumab
2
romidepsin
2
poly ICLC
2
infigratinib
2
erdafitinib
2
cc-486
2
belinostat
2
avelumab
2
amminedichloro(2-methylpyridine)platinum(II)
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 1
×
Urinary Bladder Neoplasms
×
Sorafenib
×
Clear all
NCT01844947
2019-04-26
VINSOR
Karolinska University Hospital
Phase 1
Completed
22 enrolled
NCT00544609
2014-10-02
SOGUG-07-01
Spanish Oncology Genito-Urinary Group
Phase 1
Completed
10 enrolled